Rebastinib
CAS: 1020172-07-9
Ref. TM-T2640
2mg | 47.00 € | ||
5mg | 68.00 € | ||
10mg | 94.00 € | ||
25mg | 169.00 € | ||
50mg | 247.00 € | ||
100mg | 370.00 € | ||
200mg | 557.00 € |
Product Information
- DCC-2036
- DCC2036
- DCC 2036
- N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea
- Dcc-2036
DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC,
Chemical properties
Technical inquiry about: TM-T2640 Rebastinib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.